Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis

Background: The use of direct oral anticoagulant (DOAC) off-label doses in atrial fibrillation (AF) patients may result in poor clinical outcomes. However, the true prevalence remains scarce. This study aims at estimating the prevalence of DOAC off-label doses in AF patients.Methods: Databases of ME...

Full description

Bibliographic Details
Main Authors: Nan-Nan Shen, Chi Zhang, Ying Hang, Zheng Li, Ling-Cong Kong, Na Wang, Jia-Liang Wang, Zhi-Chun Gu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Pharmacology
Subjects:
atrial fibrillation
direct oral anticoagulants
off-label doses
prevalence
dabigatran
rivaroxaban (Bay-59-7939)
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.581293/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.581293/full

Similar Items